These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 16614753)
21. Advances and challenges in understanding the multifaceted pathogenesis of amyotrophic lateral sclerosis. Laferriere F; Polymenidou M Swiss Med Wkly; 2015; 145():w14054. PubMed ID: 25635517 [TBL] [Abstract][Full Text] [Related]
22. Distinct pathological features of the gallyas- and tau-positive glia in the Parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. Oyanagi K; Makifuchi T; Ohtoh T; Chen KM; Gajdusek DC; Chase TN J Neuropathol Exp Neurol; 1997 Mar; 56(3):308-16. PubMed ID: 9056545 [TBL] [Abstract][Full Text] [Related]
23. Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS). Vanoni C; Massari S; Losa M; Carrega P; Perego C; Conforti L; Pietrini G J Cell Sci; 2004 Oct; 117(Pt 22):5417-26. PubMed ID: 15466883 [TBL] [Abstract][Full Text] [Related]
24. Pathogenic or protective? Neuropeptide Y in amyotrophic lateral sclerosis. Clark CM; Clark RM; Hoyle JA; Dickson TC J Neurochem; 2021 Feb; 156(3):273-289. PubMed ID: 32654149 [TBL] [Abstract][Full Text] [Related]
25. FUS/TLS-immunoreactive neuronal and glial cell inclusions increase with disease duration in familial amyotrophic lateral sclerosis with an R521C FUS/TLS mutation. Suzuki N; Kato S; Kato M; Warita H; Mizuno H; Kato M; Shimakura N; Akiyama H; Kobayashi Z; Konno H; Aoki M J Neuropathol Exp Neurol; 2012 Sep; 71(9):779-88. PubMed ID: 22878663 [TBL] [Abstract][Full Text] [Related]
26. Amyotrophic lateral sclerosis associated with genetic abnormalities in the gene encoding Cu/Zn superoxide dismutase: molecular pathology of five new cases, and comparison with previous reports and 73 sporadic cases of ALS. Ince PG; Tomkins J; Slade JY; Thatcher NM; Shaw PJ J Neuropathol Exp Neurol; 1998 Oct; 57(10):895-904. PubMed ID: 9786240 [TBL] [Abstract][Full Text] [Related]
27. CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. Beers DR; Henkel JS; Zhao W; Wang J; Appel SH Proc Natl Acad Sci U S A; 2008 Oct; 105(40):15558-63. PubMed ID: 18809917 [TBL] [Abstract][Full Text] [Related]
28. [Pathology of neurodegenerative diseases: with special reference to Parkinson's disease and amyotrophic lateral sclerosis]. Takahashi H Rinsho Shinkeigaku; 2002 Nov; 42(11):1085-7. PubMed ID: 12784672 [TBL] [Abstract][Full Text] [Related]
29. Expression of the small heat-shock protein alphaB-crystallin in tauopathies with glial pathology. Dabir DV; Trojanowski JQ; Richter-Landsberg C; Lee VM; Forman MS Am J Pathol; 2004 Jan; 164(1):155-66. PubMed ID: 14695329 [TBL] [Abstract][Full Text] [Related]
30. Impaired glutamate uptake and EAAT2 downregulation in an enterovirus chronically infected human glial cell line. Legay V; Deleage C; Beaulieux F; Giraudon P; Aymard M; Lina B Eur J Neurosci; 2003 May; 17(9):1820-8. PubMed ID: 12752781 [TBL] [Abstract][Full Text] [Related]
31. Keap1 is localized in neuronal and glial cytoplasmic inclusions in various neurodegenerative diseases. Tanji K; Maruyama A; Odagiri S; Mori F; Itoh K; Kakita A; Takahashi H; Wakabayashi K J Neuropathol Exp Neurol; 2013 Jan; 72(1):18-28. PubMed ID: 23242280 [TBL] [Abstract][Full Text] [Related]
32. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Tu PH; Raju P; Robinson KA; Gurney ME; Trojanowski JQ; Lee VM Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3155-60. PubMed ID: 8610185 [TBL] [Abstract][Full Text] [Related]
33. Transforming growth factor-β plasma levels and its role in amyotrophic lateral sclerosis. Duque T; Gromicho M; Pronto-Laborinho AC; de Carvalho M Med Hypotheses; 2020 Jun; 139():109632. PubMed ID: 32085981 [TBL] [Abstract][Full Text] [Related]
34. Revisiting the concept of amyotrophic lateral sclerosis as a multisystems disorder of limited phenotypic expression. Strong MJ Curr Opin Neurol; 2017 Dec; 30(6):599-607. PubMed ID: 28914734 [TBL] [Abstract][Full Text] [Related]
35. The role of excitotoxicity in neurodegenerative disease: implications for therapy. Doble A Pharmacol Ther; 1999 Mar; 81(3):163-221. PubMed ID: 10334661 [TBL] [Abstract][Full Text] [Related]
36. Roots to start research in amyotrophic lateral sclerosis: molecular pathways and novel therapeutics for future. Harikrishnareddy D; Misra S; Upadhyay S; Modi M; Medhi B Rev Neurosci; 2015; 26(2):161-81. PubMed ID: 25720096 [TBL] [Abstract][Full Text] [Related]
37. TDP-43 in amyotrophic lateral sclerosis - is it a prion disease? Ludolph AC; Brettschneider J Eur J Neurol; 2015 May; 22(5):753-61. PubMed ID: 25846565 [TBL] [Abstract][Full Text] [Related]
38. Rapidly progressive amyotrophic lateral sclerosis is associated with microglial reactivity and small heat shock protein expression in reactive astrocytes. Gorter RP; Stephenson J; Nutma E; Anink J; de Jonge JC; Baron W; Jahreiβ MC; Belien JAM; van Noort JM; Mijnsbergen C; Aronica E; Amor S Neuropathol Appl Neurobiol; 2019 Aug; 45(5):459-475. PubMed ID: 30346063 [TBL] [Abstract][Full Text] [Related]